Tien Liang BioTech Co (ROCO:4127) Common Stock: NT$457.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4127 Tien Liang BioTech Co Ltd ROCO:4127
30 GF Score
Price NT$73.50
GF Value NT$39.16
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Tien Liang BioTech Co Common Stock?

Tien Liang BioTech Co ROCO:4127 -0.81% 30 Common Stock is NT$457.6 Mil as of Dec. 2025. GuruFocus rates ROCO:4127 with a GF Score™ of 30/100 and a GF Value™ of NT$39.16 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Tien Liang BioTech Co's quarterly common stock stayed the same from Jun. 2025 (NT$457.6 Mil) to Sep. 2025 (NT$457.6 Mil) and stayed the same from Sep. 2025 (NT$457.6 Mil) to Dec. 2025 (NT$457.6 Mil).

Tien Liang BioTech Co's annual common stock stayed the same from Dec. 2023 (NT$457.6 Mil) to Dec. 2024 (NT$457.6 Mil) and stayed the same from Dec. 2024 (NT$457.6 Mil) to Dec. 2025 (NT$457.6 Mil).

Tien Liang BioTech Co Common Stock Historical Data

* Premium members only.

The historical data trend for Tien Liang BioTech Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tien Liang BioTech Co Common Stock Chart

Tien Liang BioTech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 457.60 457.60 457.60 457.60 457.60

Tien Liang BioTech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 457.60 457.60 457.60 457.60 457.60
ROCO:4127
30GF Score
Tien Liang BioTech Co Ltd ROCO:4127
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tien Liang BioTech Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$457.6 Mil mean?
Tien Liang BioTech Co (ROCO:4127) has a Common Stock of NT$457.6 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tien Liang BioTech Co and its competitors.
Is Tien Liang BioTech Co's Common Stock too high?
Tien Liang BioTech Co's current Common Stock is NT$457.6 Mil. Overall, Tien Liang BioTech Co has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tien Liang BioTech Co's Common Stock compare to ZTS?
Tien Liang BioTech Co's Common Stock of NT$457.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Tien Liang BioTech Co and its competitors. Tien Liang BioTech Co's current Common Stock is NT$457.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tien Liang BioTech Co stock overvalued right now?
Based on GuruFocus' analysis, Tien Liang BioTech Co (ROCO:4127) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$39.16, compared to a current price of NT$73.50 — trading 87.7% above its estimated fair value. The current Common Stock is NT$457.6 Mil. Tien Liang BioTech Co's overall GF Score™ is 30/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Tien Liang BioTech Co (ROCO:4127), the current Common Stock is NT$457.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tien Liang BioTech Co (ROCO:4127) Overvalued in 2026?

Based on GuruFocus' analysis, Tien Liang BioTech Co stock appears to be overvalued. The current stock price of NT$73.50 is trading 87.7% above its estimated GF Value™ of NT$39.16. GuruFocus considers Tien Liang BioTech Co to be Significantly Overvalued.

Key valuation signals for ROCO:4127:

  • Common Stock: NT$457.6 Mil
  • GF Value™: NT$39.16 vs. price of NT$73.50 (87.7% above fair value)
  • GF Score™: 30/100 with 7 warning signs

No single metric tells the full story. See the ROCO:4127 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tien Liang BioTech Co Business Description

Address No. 147, Section 1, Datong Road, 9th Floor, Xizhi District, New Taipei City, TWN
Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical, and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis, and hepatic diseases.
30GF Score

Get the complete analysis for ROCO:4127

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$73.50
Price
NT$39.16
GF Value